Provia Laboratories is a revenue-generating stem cell company focused on cGMP autologous cell manufacturing. Provia’s initial application of its technology, Store-A-Tooth™, provides private banking of stem cells from children’s teeth for future use in personalized regenerative medicine. Store-A-Toot…
Provia Laboratories is a revenue-generating stem cell company focused on cGMP autologous cell manufacturing. Provia’s initial application of its technology, Store-A-Tooth™, provides private banking of stem cells from children’s teeth for future use in personalized regenerative medicine. Store-A-Tooth™ is similar to cord blood stem cell banks like ViaCord (purchased by PerkinElmer) and Cord Blood Registry.
In addition to consumer services, Provia provides commercial stem cell and biobanking products and services such as cryo-storage, mesenchymal stem cells specimens for research, specimen storage containers, and cell manufacturing.
Team (1)
Sectors Provia Laboratories serves:
Consumer Services
Technology
Join Axial's Private M&A Platform
Provia Laboratories connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
